SCHEMBL6526778

SCHEMBL6526778

CCOC(=O)C(F)(F)F.O=C(CC(=O)C(F)(F)F)c1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLOD2 O00469 3/20 0.53
PLOD3 O60568 2/20 0.48
PLOD1 Q02809 2/20 0.48
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ABCB11 O95342 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
HTR2A P28223 1/20 0.47
PMP22 Q01453 1/20 0.47
PPARA Q07869 1/20 0.47
ALDH1A1 P00352 6/20 0.43
OPRK1 P41145 1/20 0.43
MAPT P10636 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ERCC5 P28715 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL584065 0.85 PLOD2 (0.70) PLOD2PLOD3PLOD1TSHRALDH1A1
SCHEMBL3247389 0.81 PLOD2 (0.60) PLOD2PLOD3PLOD1TSHRSMN1; SMN2
SCHEMBL22804709 0.80 PLOD2 (0.58) PLOD2PLOD3PLOD1CYP3A4MAPT
SCHEMBL276803 0.76 SMN1; SMN2 (0.61) TSHRSMN1; SMN2ALDH1A1MAPTL3MBTL1
SCHEMBL1593867 0.75 PLOD2 (0.70) PLOD2PLOD3PLOD1SMN1; SMN2ALDH1A1
SCHEMBL10596544 0.75 TSHR (0.56) TSHRSMN1; SMN2ABCB11CYP1A2CYP3A4
SCHEMBL4587003 0.75 PLOD2 (0.60) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL22804864 0.74 NR4A2 (0.61) PLOD2SMN1; SMN2ALDH1A1MAPTL3MBTL1
SCHEMBL1115952 0.74 GAA (0.52) PLOD2PLOD3PLOD1SMN1; SMN2ALDH1A1
SCHEMBL10613378 0.74 PLOD2 (0.68) PLOD2PLOD3PLOD1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005027918-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS COMPRISING COMBINATIONS OF 2-ALKYLIDENE-19-NOR-VITAMIN D DERIVATIVES AND A CYCLOOXGENASE-2 INHIBITOR PFIZER PRODUCTS INC. (US) 2005-03-31 WO disclosed